Mechanisms of immune stimulation by bacterial DNA

No abstract is available for this paper.

• Publication year

  2009

• Venue

  Springer Seminars in Immunopathology

• Publication date

  Unknown publication date

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1007/s002810000021PMID 10944797
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• CpG‐oligodeoxynucleotides co‐stimulate primary T cells in the absence of antigen‐presenting cells

  1999cited by this paper
• Differential regulation of the IL-12 p40 promoter and of p40 secretion by CpG DNA and lipopolysaccharide.

  1999cited by this paper
• Immunostimulatory properties of genomic DNA from different bacterial species.

  1999cited by this paper
• Rapid induction of mitogen-activated protein kinases by immune stimulatory CpG DNA.

  1998cited by this paper
• CpG motifs in bacterial DNA activate leukocytes through the pH-dependent generation of reactive oxygen species.

  1998cited by this paper
• IFN-gamma primes macrophage responses to bacterial DNA.

  1998cited by this paper
• CpG‐DNA‐specific activation of antigen‐presenting cells requires stress kinase activity and is preceded by non‐specific endocytosis and endosomal maturation

  1998cited by this paper
• CpG DNA Rescue from Anti-IgM-Induced WEHI-231 B Lymphoma Apoptosis via Modulation of IκBα and IκBβ and Sustained Activation of Nuclear Factor-κB/c-Rel

  1998cited by this paper
• IFN-γ Primes Macrophage Responses to Bacterial DNA

  1998cited by this paper
• CpG DNA rescue from anti-IgM-induced WEHI-231 B lymphoma apoptosis via modulation of I kappa B alpha and I kappa B beta and sustained activation of nuclear factor-kappa B/c-Rel.

  1998cited by this paper
• Bacterial DNA and immunostimulatory CpG oligonucleotides trigger maturation and activation of murine dendritic cells

  1998cited by this paper
• Sequence motifs in adenoviral DNA block immune activation by stimulatory CpG motifs.

  1998cited by this paper
• The influence of base sequence on the immunological properties of defined oligonucleotides.

  1998cited by this paper
• The Influence of DNA Sequence on the Immunostimulatory Properties of Plasmid DNA Vectors

  1998cited by this paper
• Involvement of specific mechanism in plasmid DNA uptake by mouse peritoneal macrophages.

  1998cited by this paper
• Bacterial DNA-induced NK cell IFN-gamma production is dependent on macrophage secretion of IL-12.

  1997cited by this paper
• Unmethylated CpG motifs protect murine B lymphocytes against Fas-mediated apoptosis.

  1997cited by this paper
• Mitogenicity of DNA from different organisms for murine B cells.

  1997cited by this paper
• Bacterial DNA-Induced NK Cell IFN-γ Production Is Dependent on Macrophage Secretion of IL-12

  1997cited by this paper
• Immune stimulation--a class effect of phosphorothioate oligodeoxynucleotides in rodents.

  1997cited by this paper
• Immunostimulatory DNA: Sequence‐dependent production of potentially harmful or useful cytokines

  1997cited by this paper
• The other side of scavenger receptors: pattern recognition for host defense

  1997cited by this paper
• Induction of NK activity in murine and human cells by CpG motifs in oligodeoxynucleotides and bacterial DNA.

  1996cited by this paper
• CpG DNA rescue of murine B lymphoma cells from anti-IgM-induced growth arrest and programmed cell death is associated with increased expression of c-myc and bcl-xL.

  1996cited by this paper
• Activation of human B cells by phosphorothioate oligodeoxynucleotides.

  1996cited by this paper
• Amplification of antibody production by phosphorothioate oligodeoxynucleotides.

  1996cited by this paper
• IFN-gamma promotes IL-6 and IgM secretion in response to CpG motifs in bacterial DNA and oligodeoxynucleotides.

  1996cited by this paper
• Immune activation by bacterial DNA: a new genetic code.

  1996cited by this paper
• Rapid immune activation by CpG motifs in bacterial DNA. Systemic induction of IL-6 transcription through an antioxidant-sensitive pathway.

  1996cited by this paper
• Macrophages ingest and are activated by bacterial DNA.

  1996cited by this paper
• Bacterial DNA Induces Murine Interferon-γ Production by Stimulation of Interleukin-12 and Tumor Necrosis Factor-α

  1996cited by this paper
• Bacterial DNA induces murine interferon-gamma production by stimulation of interleukin-12 and tumor necrosis factor-alpha.

  1996cited by this paper
• In vitro inhibition of murine IFN gamma production by phosphorothioate deoxyguanosine oligomers.

  1995cited by this paper
• CpG motifs in bacterial DNA trigger direct B-cell activation

  1995cited by this paper
• Binding of oligoguanylate to scavenger receptors is required for oligonucleotides to augment NK cell activity and induce IFN.

  1994cited by this paper
• G-quartet structures in telomeric DNA.

  1994cited by this paper
• Influence of Base Composition on Membrane Binding and Cellular Uptake of 10-mer Phosphorothioate Oligonucleotides in Chinese Hamster Ovary (CHRC5) Cells

  1994cited by this paper
• Lipofection of Synthetic Oligodeoxyribonucleotide Having a Palindromic Sequence of AACGTT to Murine Splenocytes Enhances Interferon Production and Natural Killer Activity

  1994cited by this paper
• Antisense oligonucleotides as therapeutic agents--is the bullet really magical?

  1993cited by this paper
• The influence of DNA structure on the in vitro stimulation of murine lymphocytes by natural and synthetic polynucleotide antigens.

  1993cited by this paper
• Oligonucleotide Sequences Required for Natural Killer Cell Activation

  1992cited by this paper
• Synthetic Oligonucleotides with Particular Base Sequences from the cDNA Encoding Proteins of Mycobacterium bovis BCG Induce Interferons and Activate Natural Killer Cells

  1992cited by this paper
• Antitumor Activity of Synthetic Oligonucleotides with Sequences from cDNA Encoding Proteins of Mycobacterium bovis BCG

  1992cited by this paper
• DNA from Bacteria, but Not from Vertebrates, Induces Interferons, Activates Natural Killer Cells and Inhibits Tumor Growth

  1992cited by this paper
• Unique palindromic sequences in synthetic oligonucleotides are required to induce IFN [correction of INF] and augment IFN-mediated [correction of INF] natural killer activity.

  1992cited by this paper
• Biological aspects of cytosine methylation in eukaryotic cells

  1991cited by this paper
• Uptake of Oligodeoxyribonucleotides by Lymphoid Cells Is Heterogeneous and Inducible

  1991cited by this paper
• Stimulation of in vitro murine lymphocyte proliferation by bacterial DNA.

  1991cited by this paper
• Patterns of DNA methylation--evolutionary vestiges of foreign DNA inactivation as a host defense mechanism. A proposal.

  1991cited by this paper
• In vitro Augmentation of Natural Killer Cell Activity and Production of Interferon‐α/β and ‐γ with Deoxyribonucleic Acid Fraction from Mycobacterium bovis BCG

  1988cited by this paper
• In vivo augmentation of natural killer cell activity with a deoxyribonucleic acid fraction of BCG.

  1986cited by this paper
• Antitumor activity of the DNA fraction from Mycobacterium bovis BCG. II. Effects on various syngeneic mouse tumors.

  1985cited by this paper
• Antitumor activity of deoxyribonucleic acid fraction from Mycobacterium bovis BCG. I. Isolation, physicochemical characterization, and antitumor activity.

  1984cited by this paper
• Antisense Oligonucleotides as Therapeutic Agents Is the Bullet Really Magical ?

  year unknowncited by this paper

• Modifying Antimicrobial Peptides with Albumin-Binding Molecules Enhances Membrane-Disrupting Efficacy by Modulating the Secondary Structure.

  2025cites this paper
• Advances in the mechanisms and applications of inhibitory oligodeoxynucleotides against immune-mediated inflammatory diseases

  2023cites this paper
• Tyrosinase-Related Protein2 Peptide with Replacement of N-Terminus Residue by Cysteine Binds to H-2Kb and Induces Antigen-Specific Cytotoxic T Lymphocytes after Conjugation with CpG-DNA.

  2023cites this paper
• Host-pathogen protein-nucleic acid interactions: A comprehensive review

  2022cites this paper
• Recent Advances in the Development of Toll-like Receptor Agonist-Based Vaccine Adjuvants for Infectious Diseases

  2022cites this paper
• Sharpening up tumor microenvironment to enhance the efficacy of immune checkpoint blockade on head and neck cancer using a CpG-oligodeoxynucleotide

  2021cites this paper
• Incorporating Gangliosides into PEGylated Cationic Liposomes that Complexed DNA Attenuates Anti-PEG Antibody Production but Not Anti-DNA Antibody Production in Mice.

  2021cites this paper
• Adjuvant Effect of Toll-Like Receptor 9 Activation on Cancer Immunotherapy Using Checkpoint Blockade

  2020influential citation
• Toll-Like Receptor 21 of Chicken and Duck Recognize a Broad Array of Immunostimulatory CpG-oligodeoxynucleotide Sequences

  2020cites this paper
• Immunostimulatory Activities of CpG-Oligodeoxynucleotides in Teleosts: Toll-Like Receptors 9 and 21

  2019cites this paper
• CpG ODN G9.1 as a novel nasal ODN adjuvant elicits complete protection from influenza virus infection without causing inflammatory immune responses.

  2019cites this paper
• CpG-oligodeoxynucleotides developed for grouper toll-like receptor (TLR) 21s effectively activate mouse and human TLR9s mediated immune responses

  2017cites this paper
• Development of CpG-Oligodeoxynucleotides for Effective Activation of Rabbit TLR9 Mediated Immune Responses

  2014cites this paper
• Toll-like receptor 9 and 21 have different ligand recognition profiles and cooperatively mediate activity of CpG-oligodeoxynucleotides in zebrafish

  2013cites this paper
• Comparative Immunology, Microbiology and Infectious Diseases

  2012cites this paper
• ctivation of rabbit TLR 9 by different CpG-ODN optimized or mouse and human TLR 9

  2012cites this paper
• Activation of rabbit TLR9 by different CpG-ODN optimized for mouse and human TLR9.

  2012cites this paper
• Extracellular Nucleic Acids Secreted by Lactobacillus Regulate TLR9 Expression

  2011cites this paper
• Molecular basis of the mucosal immune system: from fundamental concepts to advances in liposome-based vaccines.

  2010cites this paper
• In vivo effects of oligodeoxynucleotides containing synthetic immunostimulatory motifs in the immune response to swine streptococcic septicemia vaccine in weaned piglets.

  2007cites this paper
• New biological approaches in asthma: DNA-based therapy.

  2007cites this paper
• In vivo immunostimulatory effects of CpG ODN in newborn piglets.

  2007cites this paper
• Transfection of human monocyte‐derived dendritic cells with CpG oligonucleotides

  2005cites this paper
• CpG Immunomer DNA Enhances Antisense Protein Kinase A RIα Inhibition of Multidrug-Resistant Colon Carcinoma Growth in Nude Mice: Molecular Basis for Combinatorial Therapy

  2005cites this paper
• Efficacy of cellular vaccines and genetic adjuvants against bacterial kidney disease in chinook salmon (Oncorhynchus tshawytscha).

  2004cites this paper
• An innately interesting decade of research in immunology

  2004cites this paper
• Role of p38 Mitogen‐Activated Protein Kinase (MAPK) for Vacuole Formation in Lipopolysaccharide (LPS)‐Stimulated Macrophages

  2004cites this paper
• Direct Evidence that Toll-like Receptor 9 (TLR9) Functionally Binds Plasmid DNA by Specific Cytosine-phosphate-guanine Motif Recognition*

  2004cites this paper
• A dinucleotide motif in oligonucleotides shows potent immunomodulatory activity and overrides species-specific recognition observed with CpG motif

  2003cites this paper
• Requirement of nucleobase proximal to CpG dinucleotide for immunostimulatory activity of synthetic CpG DNA.

  2003cites this paper
• A DNA vaccine expressing tyrosinase-related protein-2 induces T-cell-mediated protection against mouse glioblastoma

  2003cites this paper
• Liposomal immunostimulatory DNA sequence (ISS-ODN): an efficient parenteral and mucosal adjuvant for influenza and hepatitis B vaccines.

  2002cites this paper
• Medicinal chemistry and therapeutic potential of CpG DNA.

  2002cites this paper
• Inhibition of murine macrophage nitric oxide production by synthetic oligonucleotides

  2002cites this paper
• Toll‐like receptor 9 mediates CpG‐DNA signaling

  2002cites this paper